PL3250181T3 - Formulacja farmaceutyczna na bazie minoksydylu do stosowania miejscowego i jej zestaw - Google Patents

Formulacja farmaceutyczna na bazie minoksydylu do stosowania miejscowego i jej zestaw

Info

Publication number
PL3250181T3
PL3250181T3 PL15798554T PL15798554T PL3250181T3 PL 3250181 T3 PL3250181 T3 PL 3250181T3 PL 15798554 T PL15798554 T PL 15798554T PL 15798554 T PL15798554 T PL 15798554T PL 3250181 T3 PL3250181 T3 PL 3250181T3
Authority
PL
Poland
Prior art keywords
minoxidil
kit
pharmaceutical formulation
topical use
based pharmaceutical
Prior art date
Application number
PL15798554T
Other languages
English (en)
Inventor
Sergio Fontana
Flavia La Forgia
Angela Assunta LOPEDOTA
Nunzio DENORA
Annalisa CUTRIGNELLI
Massimo Franco
Valentino Laquintana
Original Assignee
Farmalabor S.R.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmalabor S.R.L. filed Critical Farmalabor S.R.L.
Publication of PL3250181T3 publication Critical patent/PL3250181T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL15798554T 2014-10-09 2015-10-08 Formulacja farmaceutyczna na bazie minoksydylu do stosowania miejscowego i jej zestaw PL3250181T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI20141770 2014-10-09
EP15798554.0A EP3250181B1 (en) 2014-10-09 2015-10-08 Minoxidil-based pharmaceutical formulation for the topical use and kit thereof
PCT/IB2015/057694 WO2016055961A1 (en) 2014-10-09 2015-10-08 Minoxidil-based pharmaceutical formulation for the topical use and kit thereof

Publications (1)

Publication Number Publication Date
PL3250181T3 true PL3250181T3 (pl) 2020-11-16

Family

ID=51904070

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15798554T PL3250181T3 (pl) 2014-10-09 2015-10-08 Formulacja farmaceutyczna na bazie minoksydylu do stosowania miejscowego i jej zestaw

Country Status (4)

Country Link
EP (1) EP3250181B1 (pl)
ES (1) ES2813433T3 (pl)
PL (1) PL3250181T3 (pl)
WO (1) WO2016055961A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107602875A (zh) * 2017-10-16 2018-01-19 青岛海之林生物科技开发有限公司 一种速溶海藻酸钠的制备方法
EP3801734A4 (en) 2018-05-30 2022-03-16 Follica, Inc. METHOD OF PROMOTING HAIR GROWTH

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4139619A (en) 1976-05-24 1979-02-13 The Upjohn Company 6-Amino-4-(substituted amino)-1,2-dihydro-1-hydroxy-2-iminopyrimidine, topical compositions and process for hair growth
US4596812A (en) 1976-05-24 1986-06-24 The Upjohn Company Methods and solutions for treating male pattern alopecia
EP0177223B1 (en) 1984-09-24 1990-02-28 Michael Mezei Pharmaceutical multi-phase composition
US5030442A (en) 1987-03-30 1991-07-09 Liposome Technology, Inc. Non-crystalline minoxidil composition
US4828837A (en) 1987-03-30 1989-05-09 Liposome Technology, Inc. Non-crystalline minoxidil composition, its production and application
FR2717683B1 (fr) 1994-03-22 1996-06-28 Fabre Pierre Cosmetique Composition capillaire à base de minoxidil.
US5834014A (en) * 1995-10-06 1998-11-10 The Regents Of The University Of Michigan Stimulation of hair follicles
US20110112125A1 (en) 2009-11-09 2011-05-12 Tritech Biopharmaceuticals Co., Ltd. Novel hair growth composition

Also Published As

Publication number Publication date
WO2016055961A1 (en) 2016-04-14
ES2813433T3 (es) 2021-03-23
EP3250181A1 (en) 2017-12-06
EP3250181B1 (en) 2020-06-03

Similar Documents

Publication Publication Date Title
HK1249103B (zh) 多環氨甲醯基吡啶酮化合物及其藥物用途
HK1244000B (zh) 多環氨基甲酰吡啶酮化合物及其藥物用途
EP3302442A4 (en) PHARMACEUTICAL FORM AND USE THEREOF
IL252477A0 (en) 2-aminopyrimidine compound, pharmaceutical structure and its use
SG11201701292XA (en) Topical formulation
EP3434285A4 (en) PHARMACEUTICAL COMPOSITION AND USES THEREOF
ZA201904704B (en) Topical cyclosporine-containing formulations and uses thereof
HK1231376A1 (zh) 局部製劑及其應用
PT3426294T (pt) Formulação farmacêutica compreendendo anticorpo, ciclodextrina e metionina
IL266537A (en) pharmaceutical preparation
GB201502845D0 (en) Topical pharmaceutical formulation
ZA201807851B (en) Pharmaceutical formulation
HK1245113A1 (zh) 藥物組合物及其用途
PL3250181T3 (pl) Formulacja farmaceutyczna na bazie minoksydylu do stosowania miejscowego i jej zestaw
PT3373976T (pt) Formulações tópicas e suas utilizações
GB201609968D0 (en) Topical pharmaceutical formulation
GB201616767D0 (en) New pharmaceutical use
AU2014901186A0 (en) Therapeutic Agents and Uses Thereof